Fundraising FoxAntengene
9 known investors
Find your way into Antengene
Sign up to see every warm intro you have to Antengene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Antengene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
Founders & leadership
Investors · 9
How we know: Decheng Capital's portfolio page · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · pharmaceutical-technology.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · pharmaceutical-technology.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements$120M disclosed across 1 round · 2019
- $120MSeries BJan 2019 · 3 sources
Boyu Capital (lead), FountainVest (lead), Celgene Corp., Celgene Corporation, Qiming Venture Partners, Taikang, TF Capital, WuXi Corporate Venture Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Antengene do?
- Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
- Who are Antengene's investors?
- Antengene's investors include Decheng Capital, Qiming Venture Partners, Boyu Capital, FountainVest Partners.
- How much funding has Antengene raised?
- Antengene has disclosed $120M raised across 1 round.